Our results regarding the correlation between ITLN1 and cirrhosis, vascular invasion, and tumor size provided clinical evidence of the correlation between ITLN1 and HCC progression, although the strength of this evidence may need to be further validated in more HCC cohorts. The gene discussed is ITLN1; the disease is neoplasm.